C32 ASTHMA: PRE-CLINICAL STUDIES: Receptor For Advanced Glycation End Products Is An Early Upstream Activator Of The Th2 Inflammatory Immune Response In Allergic Asthma
Saved in:
Published in | American journal of respiratory and critical care medicine Vol. 189; p. 1 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
New York
American Thoracic Society
01.01.2014
|
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!